YDD-11300-27130 · OpenVSafe

Timeline

Registration Vaccinations Survey responses Call reports Cases without a report Call attempts Call successful Pregnancy survey

2021-01-05
Registered in v-safe
2021-01-05
Dose 1 — Pfizer-BioNTech
2021-01-06
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-07
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Site: Pain · None

Adult check-in
2021-01-08
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-09
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-10
Health check-in — days 1–6 daily, dose 1
Feeling: Good · Headache

Adult check-in
2021-01-11
Health check-in — days 1–6 daily, dose 1
Feeling: Good · None

Adult check-in
2021-01-12
Health check-in — day 7, dose 1
Feeling: Good · None

Adult check-in
2021-01-19
Health check-in — day 14, dose 1
Feeling: Good

Adult check-in
2021-01-26
Dose 2 — Pfizer-BioNTech
2021-02-09
Survey response — day 14, dose 2
MedDRA: Headache, Oropharyngeal pain, Pain, Rhinorrhoea — Feeling: Fair · Be unable to do your normal daily activities

Free text: Body aches, runny nose, sore throat, headache

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-02-16
Health check-in — day 21, dose 2
Feeling: Good

Adult check-in
2021-02-23
Health check-in — day 28, dose 2
Feeling: Good

Adult check-in
2021-03-09
Health check-in — day 42, dose 2
Feeling: Good

Adult check-in
2021-04-27
Survey response — 3 months, dose 2
MedDRA: Adverse reaction, Unevaluable event — Feeling: Good

Free text: Unsuccessful attempts to conceive a child

MedDRA releases: 2021-09,2023-04,2024-11 · check-in free text available
2021-07-27
Health check-in — 6 months, dose 2
Feeling: Good

Adult check-in
2022-01-29
Survey response — 12 months, dose 2
MedDRA: Placenta praevia — Feeling: Good · Be unable to work or attend school, Be unable to do your normal daily activities, Get care from a doctor or other healthcare professional · Hospitalization

Free text: Placenta previa

MedDRA releases: 2024-11 · check-in free text available
2022-01-29
Report sent to call center — 12 months, dose 2
Be unable to work or attend school · Be unable to do your normal daily activities · Get care from a doctor or other healthcare pr

Hospitalization · 1 call case(s)
2022-02-01
Call 1 — Left Voicemail

Vaccinations

Dose	Date	Manufacturer	Co-administered
1	2021-01-05	Pfizer-BioNTech
2	2021-01-26	Pfizer-BioNTech

Call center

Reported	Outcome	VAERS-related outcome
2022-01-29	Unsuccessful

Free text

Release 3 — day 14, dose 2

2021-02-09

Symptoms: Body aches, runny nose, sore throat, headache

Release 8 — 3 months, dose 2

2021-04-27

Symptoms: Unsuccessful attempts to conceive a child

Release 11 — 12 months, dose 2

2022-01-29

Symptoms: Placenta previa

Each entry is dated by the survey it was written in (the CDC re-sent the releases with survey dates in 2025); click a date to see that survey response. The CDC cut some text off at about 250 characters: symptoms in every release, and the other two fields in releases 9-12. Those entries are marked "cut off by CDC".

MedDRA terms by release

Field	Preferred term	2021-09	2023-04	2024-11
SD	Adverse reaction	✓	✓	○
SD	Headache	✓	✓	✓
SD	Oropharyngeal pain	✓	✓	✓
SD	Pain	✓	✓	✓
SD	Placenta praevia	·	·	✓
SD	Rhinorrhoea	✓	✓	✓
SD	Unevaluable event	·	·	✓

✓ active code · ○ coded but marked inactive · blank = not in that release